Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Clinical trial NCT01470443 · UNKNOWN

Trial details

NCT number: NCT01470443
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer

Start date: 2011-12-28
Primary completion: 2016-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.